DOCSLIB.ORG

What Are Oral Cavity and Oropharyngeal Cancers?

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
What Are Oral Cavity and Oropharyngeal Cancers? cancer.org | 1.800.227.2345 About Oral Cavity and Oropharyngeal Cancer Overview and Types If you've been diagnosed with oral cavity or oropharyngeal cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. ● What Are Oral Cavity and Oropharyngeal Cancers? Research and Statistics See the latest estimates for new cases of oral cavity and oropharyngeal cancers in the US and what research is currently being done. ● Key Statistics for Oral Cavity and Oropharyngeal Cancers ● What’s New in Oral Cavity and Oropharyngeal Cancer Research? What Are Oral Cavity and Oropharyngeal Cancers? Oral cavity cancer starts in the mouth. It might also be called oral cancer. Oropharyngeal cancer starts in the middle part of the throat just behind the oral cavity that can be seen when the mouth is open. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 Cancer starts when cells in the body start to grow out of control. To learn more about how cancers start and spread, see What Is Cancer?1 The oral cavity (mouth) and oropharynx (throat) The oral cavity includes the lips, the inside lining of the lips and cheeks (buccal mucosa), the teeth, the gums, the front two-thirds of the tongue, the floor of the mouth below the tongue, the bony roof of the mouth (hard palate) and the area behind the wisdom teeth (called the retromolar trigone). The oropharynx is the middle part of the throat just behind the oral cavity. It can be seen when your mouth is wide open. It includes the base of the tongue (the back third of the tongue), the soft palate (the back part of the roof of the mouth), the tonsils, and the side and back walls of the throat. The oral cavity and oropharynx help you breathe, talk, eat, chew, and swallow. Minor salivary glands all over the oral cavity and oropharynx make saliva (spit) that keeps your mouth and throat moist and helps you digest food. Ask your doctor to explain or show you where your cancer is. Explore the 3D interactive model here to learn more. Types of oral cavity (mouth) and oropharynx (throat) cancers The different parts of the oral cavity and oropharynx are made up of many types of cells. Different cancers can start in each type of cell. These differences are important, because they can determine a person’s treatment options and prognosis (outlook). Squamous cell carcinoma of the oral cavity and oropharynx Almost all of the cancers in the oral cavity and oropharynx are squamous cell carcinomas, also called squamous cell cancers. These cancers start in squamous cells, which are flat, thin cells that form the lining of the mouth and throat. The earliest form of squamous cell cancer is called carcinoma in situ. Thismeans that the cancer cells are only in the layer of cells called the epithelium(the top layer of cells lining the oral cavity and oropharynx). This is different from invasive squamous cell cancer, where the cancer cells have grown past the epithelium, into the deeper layers of the oral cavity or oropharynx. HPV-related cancers: Infection with certain high-risk types of the human papillomavirus 2 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 (HPV)2 causes most of the squamous cell cancers of the oropharynx (called HPV- positive cancer). HPV is rarely associated with oral cavity cancer. HPV-positive cancers are seen more often in young people with no history of tobacco or alcohol use. These cancers tend to have a better outcome (prognosis) than squamous cell cancers not related to an HPV infection (HPV-negative cancer). This is most likely because HPV-positive cancers shrink when treated with chemotherapy and radiation. See Risk Factors for Oral Cavity and Oropharyngeal Cancers 3. Verrucous carcinoma is a rare type of squamous cell cancer that is most often found in the gums and cheeks. It's a low-grade (slow growing) cancer that hardly ever spreads to other parts of the body. Other types of oral cavity and oropharynx cancers Minor salivary gland cancers: These cancers can start in the glands in the lining of the mouth and throat. There are many types of minor salivary gland cancers, including adenoid cystic carcinoma, mucoepidermoid carcinoma, and polymorphous low-grade adenocarcinoma. To learn more about these cancers, as well as benign salivary gland tumors, see Salivary Gland Cancer4. Lymphomas: The tonsils and base of the tongue contain immune system (lymphoid) tissue, where cancers called lymphomas can start. For more information about these cancers, see Non-Hodgkin Lymphoma5 and Non-Hodgkin Lymphoma in Children6. Leukoplakia and erythroplakia (possible pre-cancer conditions) Leukoplakia and erythroplakia are terms used to describe certain types of tissue changes that can be seen in the mouth or throat: ● Leukoplakia is a white or gray area that does not come off when scraped. ● Erythroplakia is a flat or slightly raised, red area that often bleeds easily if it's scraped. ● Erythroleukoplakia is a patch with both red and white areas. Your dentist or dental hygienist may be the first person to find these white or red patches. They might be cancer, they might be a pre-cancer condition called dysplasia, or they could be a harmless change. The most common causes of leukoplakia and erythroplakia are smoking and chewing tobacco. Poorly fitting dentures that rub against the tongue or the inside of the cheeks 3 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 can also cause these changes. But sometimes, there's no clear cause. Most cases of leukoplakia do not turn into cancer. But some leukoplakias are either cancer when first found or have pre-cancer changes that can turn into cancer if not properly treated. Erythroplakia and erythroleukoplakia are less common, but are usually more serious. More of these red lesions (compared to white lesions or leukoplakia) turn out to be cancer when they are biopsied or will develop into cancer later. Dysplasia is a term that might be used to describe leukoplakia or erythroplakia. Dysplasia can be called mild, moderate, or severe, based on how abnormal the cells look in the lab. Knowing the degree of dysplasia helps predict how likely a lesion is to turn into cancer or go away on its own. For example, severe dysplasia is more likely than mild dysplasia to become cancer. Dysplasia may sometimes go away if the cause (such as poorly fitting dentures) is removed. A biopsy is the only way to know for certain if an area of leukoplakia or erythroplakia has dysplastic (pre-cancer) cells or cancer cells. (See Tests for Oral Cavity and Oropharyngeal Cancers7.) But other tests might be used first to help determine if a biopsy is needed or to choose the best area to sample for a biopsy. These tests are described in Can Oral Cavity and Oropharyngeal Cancers Be Found Early?8 Still, it's important to note that most oral cancers do not develop from pre-existing lesions (either leukoplakia or erythroplakia). Benign (not cancer) tumors Many types of benign tumors and tumor-like changes can start in the mouth or throat, such as these: ● Peripheral giant cell granuloma ● Fibroma ● Granular cell tumor ● Schwannoma ● Neurofibroma ● Pyogenic granuloma ● Oral hemangioma These non-cancer tumors start from different kinds of cells and have many causes. Some of them may cause problems, but they're not likely to be life-threatening. The usual treatment for these types of tumors is surgery to remove them completely since they are unlikely to recur (come back). 4 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 Hyperlinks 1. www.cancer.org/cancer/cancer-basics/what-is-cancer.html 2. www.cancer.org/cancer/cancer-causes/infectious-agents/hpv/hpv-and-cancer- info.html 3. www.cancer.org/cancer/oral-cavity-and-oropharyngeal-cancer/causes-risks- prevention/risk-factors.html 4. www.cancer.org/cancer/salivary-gland-cancer.html 5. www.cancer.org/cancer/non-hodgkin-lymphoma.html 6. www.cancer.org/cancer/childhood-non-hodgkin-lymphoma.html 7. www.cancer.org/cancer/oral-cavity-and-oropharyngeal-cancer/detection-diagnosis- staging/how-diagnosed.html 8. www.cancer.org/cancer/oral-cavity-and-oropharyngeal-cancer/detection-diagnosis- staging/detection.html References American Joint Committee on Cancer. Lip and Oral Cavity. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017:79. American Joint Committee on Cancer. Oropharynx (p16-) and Hypopharynx. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017:123. Leeman JE, Katabi N, Wong RJ, Lee NY, Romesser PB. Ch. 65 - Cancer of the Head and Neck. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier; 2020. Maymone MBC, Greer RO, Burdine LK, Dao-Cheng A, Venkatesh S, Sahitya PC, Maymone AC, Kesecker J, Vashi NA. Benign oral mucosal lesions: Clinical and pathological findings. J Am Acad Dermatol. 2019 Jul;81(1):43-56. doi: 10.1016/j.jaad.2018.09.061. Epub 2018 Nov 14. PMID: 30447312. Mendenhall WM, Dziegielewski PT, Pfister DG. Chapter 45- Cancer of the Head and Neck. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 11th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2019. National Cancer Institute. Physician Data Query (PDQ). Lip and Oral Cavity Cancer Treatment. September 05, 2019. Accessed at https://www.cancer.gov/types/head-and- 5 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 neck/hp/adult/lip-mouth-treatment-pdq on September 21, 2020. National Cancer Institute.
Load more

Recommended publications
  • Glossary for Narrative Writing
    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
    [Show full text]
  • Network Scan Data
    CTEP Protocol No: T-99-0090 CC Protocol No: 01-C-0222 Amendment: J Revised: 4/21/09 IRB Approval Date: A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas Coordinating Center: Pediatric Oncology Branch, NCI Principal Investigator: Brigitte Widemann, M.D.* (POB, NCI) NIH Associate Investigators: Frank M. Balis, M.D. (POB, NCI) Beth Fox, M.D. (POB, NCI) Kathy Warren, M.D. (NOB, NCI) Andy Gillespie, R.N. (ND, CC) Eva Dombi, MD (POB, NCI)** Nalini Jayaprakash, (POB, NCI) Diane Cole, (POB, NCI) Seth Steinberg, Ph.D. (BDMB, DCS, NCI) Nicholas Patronas, M.D. (DR, CC)** Maria Tsokos, M.D., (Laboratory of Pathology, NCI)** Pamela Wolters, Ph.D. (HAMB, NCI) Staci Martin, Ph.D. (HAMB, NCI) Jeffrey Solomon, (NIH and Sensor Systems, Inc.) Non-NIH Associate Investigators: Wanda Salzer, M.D. ** Keesler Air Force Base, Biloxi, Mississippi) 81st MDOS/SGOC 301 Fisher Street, Room 1A132 Keesler AFB, MS 39534-2519 Phone: 228-377-6524 E-mail: [email protected] Bruce R. Korf, M.D., Ph.D. ** Chair, Department of Genetics Univeristy of Alabama at Birmingham 1530 3rd Ave. S. Birmingham, AL 35294 Phone: (205)-934-9411, Fax: (205)-934-9488 E-mail: [email protected] David H. Gutmann, M.D., Ph.D. ** Department of Neurology Washington University School of Medicine St. Louis Children’s Hospital Box 8111, 660 S. Euclid Avenue St. Louis, MO 63110 Phone: (314)-632-7149, Fax: (314)-362-9462 E-mail: [email protected] 1 4/21/2009 T-99-0090, 01-C-0222 Arie Perry, M.D.
    [Show full text]
  • Mouth Esophagus Stomach Rectum and Anus Large Intestine Small
    1 Liver The liver produces bile, which aids in digestion of fats through a dissolving process known as emulsification. In this process, bile secreted into the small intestine 4 combines with large drops of liquid fat to form Healthy tiny molecular-sized spheres. Within these spheres (micelles), pancreatic enzymes can break down fat (triglycerides) into free fatty acids. Pancreas Digestion The pancreas not only regulates blood glucose 2 levels through production of insulin, but it also manufactures enzymes necessary to break complex The digestive system consists of a long tube (alimen- 5 carbohydrates down into simple sugars (sucrases), tary canal) that varies in shape and purpose as it winds proteins into individual amino acids (proteases), and its way through the body from the mouth to the anus fats into free fatty acids (lipase). These enzymes are (see diagram). The size and shape of the digestive tract secreted into the small intestine. varies in each individual (e.g., age, size, gender, and disease state). The upper part of the GI tract includes the mouth, throat (pharynx), esophagus, and stomach. The lower Gallbladder part includes the small intestine, large intestine, The gallbladder stores bile produced in the liver appendix, and rectum. While not part of the alimentary 6 and releases it into the duodenum in varying canal, the liver, pancreas, and gallbladder are all organs concentrations. that are vital to healthy digestion. 3 Small Intestine Mouth Within the small intestine, millions of tiny finger-like When food enters the mouth, chewing breaks it 4 protrusions called villi, which are covered in hair-like down and mixes it with saliva, thus beginning the first 5 protrusions called microvilli, aid in absorption of of many steps in the digestive process.
    [Show full text]
  • Clinical Implications of HPV in Head and Neck Cancers
    VOLUME 24 ⅐ NUMBER 17 ⅐ JUNE 10 2006 JOURNAL OF CLINICAL ONCOLOGY REVIEW ARTICLE Clinical Implications of Human Papillomavirus in Head and Neck Cancers Carole Fakhry and Maura L. Gillison From the Departments of Viral Oncol- ABSTRACT ogy, Aerodigestive Malignancy, and Cancer Prevention and Control, The Human papillomavirus (HPV) is now recognized to play a role in the pathogenesis of a subset of head and neck Sidney Kimmel Comprehensive Cancer squamous cell carcinomas (HNSCCs), particularly those that arise from the lingual and palatine tonsils within Center at Johns Hopkins; and the the oropharynx. High-risk HPV16 is identified in the overwhelming majority of HPV-positive tumors, which have Departments of Epidemiology and molecular-genetic alterations indicative of viral oncogene function. Measures of HPV exposure, including Molecular Microbiology and Immunol- sexual behaviors, seropositivity to HPV16, and oral, high-risk HPV infection, are associated with increased risk ogy, The Johns Hopkins Bloomberg for oropharyngeal cancer. HPV infection may be altering the demographics of HNSCC patients, as these School of Public Health, Baltimore, MD. patients tend to be younger, nonsmokers, and nondrinkers. There is sufficient evidence to conclude that a Submitted February 9, 2006; accepted diagnosis of HPV-positive HNSCC has significant prognostic implications; these patients have at least half the February 27, 2006. risk of death from HNSCC when compared with the HPV-negative patient. The HPV etiology of these tumors Supported in part by National Institute may have future clinical implications for the diagnosis, therapy, screening, and prevention of HNSCC. for Dental and Craniofacial Research Grant No. DE016631-02. J Clin Oncol 24:2606-2611.
    [Show full text]
  • 50 Facts About Oral Head and Neck Cancer
    50 Facts about Oral, Head and Neck Cancer 1. Oral, Head and Neck Cancer most commonly refers to squamous cell carcinoma of the tongue, throat, and voice box. However, often, head and neck cancer also refers to other types of cancer that arises in the nasal cavity, sinuses, lips, mouth, thyroid glands, salivary glands, throat, or voice box. 2. HPV or human papillomavirus appears to be responsible for the rise in cancers of the oropharynx (tonsil and base of tongue) in younger nonsmokers and is related to oral sex. 3. Tobacco and alcohol use are the leading causes of mouth and voice box cancers. 4. Cancers of the head and neck account for 6 percent of all malignancies in the United States. 5. Caucasians currently have the highest incidence rates of head and neck cancers, although death is still highest in African Americans. 6. Tobacco (including smokeless tobacco) and alcohol use are very important risk factors for oral, head and neck cancers, particularly those of the tongue, mouth, throat and voice box. Chewing tobacco has been shown to cause mouth cancer. Human Papilloma Virus may be related to over half of tonsil cancers. 7. Cigarette smoking increases your risk of head and neck cancer by 15 times compared to a non-smoker. 8. People who use both tobacco and alcohol are at greater risk than people who use them alone. 9. Oral, Head and Neck cancers tend to form in the areas where tobacco/alcohol use has the most contact. For example, where the cigarette sits on the lip, or where the chewing tobacco is placed in the mouth.
    [Show full text]
  • Study of Oropharyngeal Ulcers with Their Commonest Anatomical Sites of Presentation Correlated with Histopathological Diagnosis Among the North Bengal Population
    Panacea Journal of Medical Sciences 2020;10(3):258–263 Content available at: https://www.ipinnovative.com/open-access-journals Panacea Journal of Medical Sciences Journal homepage: www.ipinnovative.com Original Research Article Study of oropharyngeal ulcers with their commonest anatomical sites of presentation correlated with histopathological diagnosis among the north Bengal population Tanwi Ghosal (Sen)1, Pallab Kr Saha2,*, Sauris Sen3 1Dept. of Anatomy, North Bengal Medical College, Sushrutanagar, West Bengal, India 2Dept. of Anatomy, NRS Medical College, Kolkata, West Bengal, India 3Dept. of ENT, Jalpaiguri District Hospital, Jalpaiguri, West Bengal, India ARTICLEINFO ABSTRACT Article history: Introduction: Oropharyngeal ulcers are very common in North East part of India due to bad oral habits like Received 31-07-2020 chewing of tobacco etc. A study was performed at North Bengal Medical College and Hospital among the Accepted 06-10-2020 patients attending otorhinolaryngology outdoor to explore the relationship of different types and proportion Available online 29-12-2020 of oropharyngeal ulcers with their commonest anatomical sites and to elicit the relationship with bad oral habits. Aims: • To elicit the different types and proportions of oropharyngeal ulcers. • To explore the relationship Keywords: of different histopathological types with anatomical sites. • To identify the relationship with addiction. Ulcer Material and Methods: This is a Cross-sectional Observational Hospital based study, conducted in the Oral Cavity Otorhinolaryngology outdoor of North Bengal Medical College and Hospital twice a week. 102 patients Oropharynx were selected as study population after maintaining inclusion and exclusion criteria. Anatomical sites Results: The study shows that the most common type of ulcer is aphthous (25.49%) and the least common types are erythroplakia and autoimmune ulcers (1.96%).
    [Show full text]
  • The Ear, Nose, and Throat Exam Jeffrey Texiera, MD and Joshua Jabaut, MD CPT, MC, USA LT, MC, USN
    The Ear, Nose, and Throat Exam Jeffrey Texiera, MD and Joshua Jabaut, MD CPT, MC, USA LT, MC, USN Midatlantic Regional Occupational and Environmental Medicine Conference Sept. 23, 2017 Disclosures ●We have no funding or financial interest in any product featured in this presentation. The items included are for demonstration purposes only. ●We have no conflicts of interest to disclose. Overview ● Overview of clinically oriented anatomy - presented in the format of the exam ● The approach ● The examination ● Variants of normal anatomy ● ENT emergencies ● Summary/highlights ● Questions Anatomy ● The head and neck exam consists of some of the most comprehensive and complicated anatomy in the human body. ● The ear, nose, and throat comprise a portion of that exam and a focused clinical encounter for an acute ENT complaint may require only this portion of the exam. Ears www.Medscape.com www.taqplayer.info Ear – Vestibular organ www.humanantomylibrary.com Nose/Sinus Anatomy Inferior Middle Turbinate Turbinate Septum Dorsum Sidewalls Ala Floor Tip www.ENT4Students.blogspot.com Columella Vestibule www.beautyepic.com Oral cavity and oropharynx (throat) www.apsubiology.org Neck www.rdhmag.com The Ear, Nose, and Throat exam Perform in a standardized systematic way that works for you Do it the same way every time, this mitigates risk of missing a portion of the exam Practice the exam to increase comfort with performance and familiarize self with variants of normal Describe what you are doing to the patient, describe what you see in your documentation Use your PPE as appropriate A question to keep in mind… ●T/F: The otoscope is the optimal tool for examining the tympanic membrane.
    [Show full text]
  • The Contagious Head and Neck Cancer
    omens H f W ea o l l th a n C r a u r e o J Hoffman-Ruddy, et al., J Women’s Health Care 2015, 4:2 Journal of Women's Health Care DOI: 10.4172/2167-0420.1000226 ISSN: 2167-0420 Review Article Open Access The Contagious Head and Neck Cancer: The Role of Human Papillomavirus HPV Bari Hoffman-Ruddy*1, Sarah Miller2, Erin Silverman3, Vicki Lewis4, Henry Ho4 and Christine Sapienza5 1Department of Communication Sciences and Disorders, University of Central Florida, College of Health and Public Affairs, Florida, USA 2University of Memphis, Loewenberg School of Nursing 3Department of Physiology, University of Florida, College of Veterinary Medicine, Florida, USA 4Florida Hospital Cancer Institute, The Ear Nose Throat and Plastic Surgery Associates 5Department of Communication Sciences and Disorders, College of Health Sciences, Brooks Rehabilitation, Jacksonville University *Corresponding author: Bari Hoffman-Ruddy, University of Central Florida, College of Health and Public Affairs, Department of Communication Sciences and Disorders, Florida, USA, Tel: 407-823-4894; Fax: 407-823-4816; E-mail: [email protected] Received date: Jan 06, 2015; Accepted date: Feb 20, 2015; Published date: Feb 25, 2015 Copyright: © 2015 Hoffman-Ruddy B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Keywords: Human papillomavirus, Head and neck cancer, have no history of significant tobacco or alcohol use [8]. In fact, rates Transmitted diseases of certain cancers of the oropharynx have increased over the last 30 years among young adults who have never smoked or used tobacco Summary products [9].
    [Show full text]
  • Medical Terminology Abbreviations Medical Terminology Abbreviations
    34 MEDICAL TERMINOLOGY ABBREVIATIONS MEDICAL TERMINOLOGY ABBREVIATIONS The following list contains some of the most common abbreviations found in medical records. Please note that in medical terminology, the capitalization of letters bears significance as to the meaning of certain terms, and is often used to distinguish terms with similar acronyms. @—at A & P—anatomy and physiology ab—abortion abd—abdominal ABG—arterial blood gas a.c.—before meals ac & cl—acetest and clinitest ACLS—advanced cardiac life support AD—right ear ADL—activities of daily living ad lib—as desired adm—admission afeb—afebrile, no fever AFB—acid-fast bacillus AKA—above the knee alb—albumin alt dieb—alternate days (every other day) am—morning AMA—against medical advice amal—amalgam amb—ambulate, walk AMI—acute myocardial infarction amt—amount ANS—automatic nervous system ant—anterior AOx3—alert and oriented to person, time, and place Ap—apical AP—apical pulse approx—approximately aq—aqueous ARDS—acute respiratory distress syndrome AS—left ear ASA—aspirin asap (ASAP)—as soon as possible as tol—as tolerated ATD—admission, transfer, discharge AU—both ears Ax—axillary BE—barium enema bid—twice a day bil, bilateral—both sides BK—below knee BKA—below the knee amputation bl—blood bl wk—blood work BLS—basic life support BM—bowel movement BOW—bag of waters B/P—blood pressure bpm—beats per minute BR—bed rest MEDICAL TERMINOLOGY ABBREVIATIONS 35 BRP—bathroom privileges BS—breath sounds BSI—body substance isolation BSO—bilateral salpingo-oophorectomy BUN—blood, urea, nitrogen
    [Show full text]
  • Study Guide Medical Terminology by Thea Liza Batan About the Author
    Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails ­proficiency­in­communicating­with­healthcare­professionals­such­as­physicians,­nurses,­ or dentists.
    [Show full text]
  • Depo-Provera
    PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR ® DEPO-PROVERA medroxyprogesterone acetate injectable suspension, USP Sterile Aqueous Suspension 50 mg/mL and 150 mg/mL Progestogen Pfizer Canada Inc. Date of Revision: 17,300 Trans-Canada Highway February 13, 2018 Kirkland, Quebec H9J 2M5 Submission Control No: 210121 ® Pharmacia & Upjohn Company LLC Pfizer Canada Inc., Licensee © Pfizer Canada Inc., 2018 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION......................................................... 3 SUMMARY PRODUCT INFORMATION ........................................................................ 3 INDICATIONS AND CLINICAL USE .............................................................................. 3 CONTRAINDICATIONS ................................................................................................... 4 WARNINGS AND PRECAUTIONS: ................................................................................ 5 ADVERSE REACTIONS ................................................................................................. 18 DRUG INTERACTIONS .................................................................................................. 27 DOSAGE AND ADMINISTRATION .............................................................................. 28 OVERDOSAGE ................................................................................................................ 30 ACTION AND CLINICAL PHARMACOLOGY ............................................................ 30 STORAGE AND
    [Show full text]
  • Clinical Radiation Oncology Review
    Clinical Radiation Oncology Review Daniel M. Trifiletti University of Virginia Disclaimer: The following is meant to serve as a brief review of information in preparation for board examinations in Radiation Oncology and allow for an open-access, printable, updatable resource for trainees. Recommendations are briefly summarized, vary by institution, and there may be errors. NCCN guidelines are taken from 2014 and may be out-dated. This should be taken into consideration when reading. 1 Table of Contents 1) Pediatrics 6) Gastrointestinal a) Rhabdomyosarcoma a) Esophageal Cancer b) Ewings Sarcoma b) Gastric Cancer c) Wilms Tumor c) Pancreatic Cancer d) Neuroblastoma d) Hepatocellular Carcinoma e) Retinoblastoma e) Colorectal cancer f) Medulloblastoma f) Anal Cancer g) Epndymoma h) Germ cell, Non-Germ cell tumors, Pineal tumors 7) Genitourinary i) Craniopharyngioma a) Prostate Cancer j) Brainstem Glioma i) Low Risk Prostate Cancer & Brachytherapy ii) Intermediate/High Risk Prostate Cancer 2) Central Nervous System iii) Adjuvant/Salvage & Metastatic Prostate Cancer a) Low Grade Glioma b) Bladder Cancer b) High Grade Glioma c) Renal Cell Cancer c) Primary CNS lymphoma d) Urethral Cancer d) Meningioma e) Testicular Cancer e) Pituitary Tumor f) Penile Cancer 3) Head and Neck 8) Gynecologic a) Ocular Melanoma a) Cervical Cancer b) Nasopharyngeal Cancer b) Endometrial Cancer c) Paranasal Sinus Cancer c) Uterine Sarcoma d) Oral Cavity Cancer d) Vulvar Cancer e) Oropharyngeal Cancer e) Vaginal Cancer f) Salivary Gland Cancer f) Ovarian Cancer & Fallopian
    [Show full text]